Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

569 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pharmacokinetics of a granisetron transdermal system for the treatment of chemotherapy-induced nausea and vomiting.
Howell J, Smeets J, Drenth HJ, Gill D. Howell J, et al. Among authors: smeets j. J Oncol Pharm Pract. 2009 Dec;15(4):223-31. doi: 10.1177/1078155209104063. J Oncol Pharm Pract. 2009. PMID: 19304880 Clinical Trial.
Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study.
Peeters PA, van den Heuvel MW, van Heumen E, Passier PC, Smeets JM, van Iersel T, Zwiers A. Peeters PA, et al. Clin Drug Investig. 2010;30(12):867-74. doi: 10.1007/BF03256915. Clin Drug Investig. 2010. PMID: 20825252 Clinical Trial.
Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PA, Smeets JM, Foubert L. Cammu G, et al. Among authors: smeets jm. Br J Anaesth. 2008 Mar;100(3):373-9. doi: 10.1093/bja/aem402. Epub 2008 Jan 31. Br J Anaesth. 2008. PMID: 18238834 Clinical Trial.
Sugammadex is not associated with QT/QTc prolongation: methodology aspects of an intravenous moxifloxacin-controlled thorough QT study.
de Kam PJ, van Kuijk J, Smeets J, Thomsen T, Peeters P. de Kam PJ, et al. Among authors: smeets j. Int J Clin Pharmacol Ther. 2012 Aug;50(8):595-604. doi: 10.5414/CP201693. Int J Clin Pharmacol Ther. 2012. PMID: 22735462 Clinical Trial.
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex.
Ploeger BA, Smeets J, Strougo A, Drenth HJ, Ruigt G, Houwing N, Danhof M. Ploeger BA, et al. Among authors: smeets j. Anesthesiology. 2009 Jan;110(1):95-105. doi: 10.1097/ALN.0b013e318190bc32. Anesthesiology. 2009. PMID: 19104176
Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach.
Zwiers A, van den Heuvel M, Smeets J, Rutherford S. Zwiers A, et al. Among authors: smeets j. Clin Drug Investig. 2011;31(2):101-11. doi: 10.2165/11584730-000000000-00000. Clin Drug Investig. 2011. PMID: 21067251
Pharmacokinetic evaluation of three different intramuscular doses of nandrolone decanoate: analysis of serum and urine samples in healthy men.
Bagchus WM, Smeets JM, Verheul HA, De Jager-Van Der Veen SM, Port A, Geurts TB. Bagchus WM, et al. J Clin Endocrinol Metab. 2005 May;90(5):2624-30. doi: 10.1210/jc.2004-1526. Epub 2005 Feb 15. J Clin Endocrinol Metab. 2005. PMID: 15713722
Sugammadex is cleared rapidly and primarily unchanged via renal excretion.
Peeters P, Passier P, Smeets J, Zwiers A, de Zwart M, van de Wetering-Krebbers S, van Iersel M, van Marle S, van den Dobbelsteen D. Peeters P, et al. Among authors: smeets j. Biopharm Drug Dispos. 2011 Apr;32(3):159-67. doi: 10.1002/bdd.747. Epub 2011 Mar 1. Biopharm Drug Dispos. 2011. PMID: 21370235
In vitro vitellogenin production by carp (Cyprinus carpio) hepatocytes as a screening method for determining (anti)estrogenic activity of xenobiotics.
Smeets JM, Rankouhi TR, Nichols KM, Komen H, Kaminski NE, Giesy JP, van den Berg M. Smeets JM, et al. Toxicol Appl Pharmacol. 1999 May 15;157(1):68-76. doi: 10.1006/taap.1999.8663. Toxicol Appl Pharmacol. 1999. PMID: 10329509
Estrogenic potencies of several environmental pollutants, as determined by vitellogenin induction in a carp hepatocyte assay.
Smeets JM, van Holsteijn I, Giesy JP, Seinen W, van den Berg M. Smeets JM, et al. Toxicol Sci. 1999 Aug;50(2):206-13. doi: 10.1093/toxsci/50.2.206. Toxicol Sci. 1999. PMID: 10478856
569 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback